Anemia as a Risk Marker: Study Links New Diagnosis to Higher Cancer and Mortality Risk

A large observational study of Swedish adults has found that individuals newly diagnosed with anemia have an increased likelihood of being diagnosed with cancer and a higher risk of death from any cause within the following 18 months. The research, published in BMJ Journals, suggests anemia may serve as a risk marker for underlying disease.

Study Overview and Methodology

Researchers from the Karolinska Institutet analyzed registry data from more than 380,000 Swedish adults. The cohort was divided into two groups:

• Half had been newly diagnosed with anemia (incident anemia).
• The other half, matched by age and gender, did not have anemia.

All participants were over 18 years old and had no cancer diagnosis at the start of the study. The research team followed the participants for 18 months.

Key Findings

The analysis revealed several associations between new-onset anemia and health outcomes.

"Our findings suggest that anemia may be a sign of underlying disease rather than a condition in its own right." — Elinor Nemlander, Lead Study Author

Cancer Diagnosis: Individuals with incident anemia had a higher likelihood of a subsequent cancer diagnosis, with the risk being highest within the first three months after anemia was detected. Within the study period, 6.2% of men and 2.8% of women with anemia were diagnosed with cancer.

Mortality: Individuals with anemia also had a higher chance of death from any cause during the 18-month follow-up period.

The study noted different associations based on red blood cell size:

• Microcytic anemia (characterized by smaller-than-normal red blood cells) was more frequently linked to a cancer diagnosis, particularly cancers of the digestive system and blood cancers.
• Macrocytic anemia (characterized by larger-than-normal red blood cells) showed a stronger association with overall mortality than with a cancer diagnosis.

Researcher Commentary

Lead study author Elinor Nemlander stated that the risks for both cancer and death were highest in the initial months after anemia detection but remained elevated throughout the follow-up period.

She noted that measurements of red blood cell size are routinely available in primary care and that the study highlights how this existing data could be used to identify early risk.

"At the same time, the elevated risks persist over time, underscoring the need for structured follow-up and clear plans for continued evaluation, even when cancer is not initially identified." — Elinor Nemlander

The researchers concluded that new-onset anemia represents a "strong and sustained risk marker" for both incident cancer and all-cause mortality.

Study Limitations

The authors outlined several limitations to their research:

• The study was observational, meaning it can show an association but cannot prove that anemia causes cancer or death.
• The research did not account for all potential causes of anemia, including alcohol use, malnutrition, chronic liver disease, inflammatory conditions, and gynecological blood loss.
• Nemlander noted that some results may be influenced by factors such as which patients get tested for anemia, underlying illnesses, and differences in how anemia is evaluated across different healthcare settings.